Fujian University of Traditional Chinese Medicine in China has reported that repetitive transcranial magnetic stimulation ...

New research suggests a statistical model may accurately predict onset of mild cognitive impairment and Alzheimer ... of the participant as well as the Clinical Dementia Rating Sum of Boxes ...

This partnership marks a significant step in leveraging the power of AI to enhance clinical trial outcomes. Perceiv AI's AD-Px™ engine, known for its ability to forecast disease progression in ...

Repetitive transcranial magnetic stimulation (rTMS) added to tai chi chuan exercise improved sleep and cognition in older adults who had both sleep disorders and mild cognitive impairment, a ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

In “The Last Alzheimer’s Patient,” CNN chief medical correspondent follows Alzheimer’s patient Cici Zerbe who says her ...

Data Synthesis: Reports of statin-associated cognitive impairment were found primarily in observational studies (eg, case reports/series). One randomized controlled trial demonstrated that ...

Background: Mild cognitive impairment (MCI) has been considered a transitional state between normal aging and dementia, characterised by memory impairment but normal general cognitive functioning.

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...

13, 2025 — Mild cognitive impairment is linked to blood vessel ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical ...

Targeting toxic oligomers without binding to plaque, designed to reduce the risk of ARIA and potentially deliver enhanced outcomes for patients ...